---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-081560"
form_type: "8-K"
ticker: "PFSA"
cik: "0001859807"
company_name: "Profusa, Inc."
filed_at: "2026-07-27T10:08:35+00:00"
generated_at: "2026-07-27T10:10:11.847335+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Profusa signs non-binding term sheet to acquire diagnostics company with ~$111M revenue; appoints new CEO

## Summary
- Non-binding term sheet to acquire a private diagnostics/toxicology testing company; 2025 net revenues estimated at ~$111M (unaudited).
- Consideration: 19.99% of Profusa common stock plus non-voting convertible preferred stock; outstanding notes also exchanged for preferred.
- Concurrent ~$7M convertible note financing expected (12-month term, 9% OID, 7% interest, 18% default rate).
- Jack Stover appointed Executive Chairman and CEO; Ben Hwang becomes President and resigns from board; Liviu Goldenberg appointed independent director.
- Transaction subject to due diligence, definitive agreements, regulatory and shareholder approvals; no assurance of completion.

## SEC filing metadata
- accession: 0001213900-26-081560
- form_type: 8-K
- ticker: PFSA
- cik: 0001859807
- company_name: Profusa, Inc.
- filed_at: 2026-07-27T10:08:35+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859807/000121390026081560/0001213900-26-081560-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859807/000121390026081560/ea0298832-8k_profusa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-081560
- JSON: https://secwatch.observer/filing/0001213900-26-081560.json
- Plain text: https://secwatch.observer/filing/0001213900-26-081560.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.